Reference answer · biosimilars · reviewed quarterly
Last updated
Review cadence: quarterlyUnderlying federal data: refreshed weekly to annual per source
Q&A library · biosimilars

what is biosimilar substitution

Biosimilar substitution is when a pharmacist dispenses an FDA-designated interchangeable biosimilar instead of the prescribed reference biologic, subject to state pharmacy law and any prescriber notification rules. Not all biosimilars are interchangeable; FDA Purple Book listings and formulary policy determine whether substitution can occur.

Related questions.

Q&A librarySourced · reviewed quarterly
biosimilarswhat is biosimilar substitution
Browse all canonical questions →